Sigachi Industries Limited, a publicly listed company on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE), has attracted investor attention due to its impressive financial performance.
In the second quarter of the financial year 2025, the company reported a 38.1 percent increase in revenue and a 39.07 percent jump in profit after tax (PAT). This growth has led to a 16 percent increase in the stock price, which is currently trading under Rs 55. With a market capitalization of Rs 1,650 crore, Sigachi Industries Limited has demonstrated consistent profit growth over the past five years, with a compound annual growth rate (CAGR) of 25 percent.
The company is known for its high-quality pharmaceutical excipients, APIs, and operational and maintenance services. It operates five manufacturing facilities and has subsidiaries in the United States and the United Arab Emirates.
The recent financial results for Q2FY25 show a significant increase in revenue, EBITDA, and PAT. The half-yearly results for H1FY24 also demonstrate the company's strong financial health.
Given its recent performance and market presence, Sigachi Industries is an attractive option for investors looking to invest in the pharmaceutical sector.